These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12782572)

  • 1. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.
    Zeng Q; Dong JM; Guo K; Li J; Tan HX; Koh V; Pallen CJ; Manser E; Hong W
    Cancer Res; 2003 Jun; 63(11):2716-22. PubMed ID: 12782572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.
    Guo K; Li J; Wang H; Osato M; Tang JP; Quah SY; Gan BQ; Zeng Q
    Cancer Res; 2006 Oct; 66(19):9625-35. PubMed ID: 17018620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL-3: a metastasis-associated phosphatase in search of a function.
    Bessette DC; Wong PC; Pallen CJ
    Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
    Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
    Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels.
    Guo K; Li J; Tang JP; Koh V; Gan BQ; Zeng Q
    Cancer Biol Ther; 2004 Oct; 3(10):945-51. PubMed ID: 15326366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.
    Wu X; Zeng H; Zhang X; Zhao Y; Sha H; Ge X; Zhang M; Gao X; Xu Q
    Am J Pathol; 2004 Jun; 164(6):2039-54. PubMed ID: 15161639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.
    Li Z; Zhan W; Wang Z; Zhu B; He Y; Peng J; Cai S; Ma J
    Biochem Biophys Res Commun; 2006 Sep; 348(1):229-37. PubMed ID: 16875667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.
    Matter WF; Estridge T; Zhang C; Belagaje R; Stancato L; Dixon J; Johnson B; Bloem L; Pickard T; Donaghue M; Acton S; Jeyaseelan R; Kadambi V; Vlahos CJ
    Biochem Biophys Res Commun; 2001 May; 283(5):1061-8. PubMed ID: 11355880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
    Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
    Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
    Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
    Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
    Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.
    Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q
    Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRL-3 expression in metastatic cancers.
    Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
    Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRL-3 phosphatase is implicated in ovarian cancer growth.
    Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.